Sotera Health (NASDAQ:SHC) Shares Acquired by Two Seas Capital LP

Two Seas Capital LP lifted its stake in Sotera Health (NASDAQ:SHC - Free Report) by 624.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,896,136 shares of the company's stock after purchasing an additional 2,496,136 shares during the quarter. Sotera Health comprises about 3.4% of Two Seas Capital LP's portfolio, making the stock its 9th largest holding. Two Seas Capital LP owned about 1.02% of Sotera Health worth $39,619,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of SHC. Price T Rowe Associates Inc. MD lifted its holdings in shares of Sotera Health by 20.3% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 89,668 shares of the company's stock worth $1,227,000 after purchasing an additional 15,156 shares during the period. Khrom Capital Management LLC purchased a new stake in shares of Sotera Health in the 4th quarter valued at $4,998,000. Tower Research Capital LLC TRC increased its stake in shares of Sotera Health by 37.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock worth $82,000 after acquiring an additional 1,640 shares during the period. Voss Capital LP raised its holdings in shares of Sotera Health by 42.9% during the fourth quarter. Voss Capital LP now owns 500,000 shares of the company's stock worth $6,840,000 after purchasing an additional 150,000 shares during the last quarter. Finally, MetLife Investment Management LLC lifted its position in Sotera Health by 9.1% during the fourth quarter. MetLife Investment Management LLC now owns 86,177 shares of the company's stock valued at $1,179,000 after purchasing an additional 7,174 shares during the period. Hedge funds and other institutional investors own 91.03% of the company's stock.

Sotera Health Trading Up 1.0 %

Shares of Sotera Health stock traded up $0.11 during trading hours on Monday, hitting $11.26. The company's stock had a trading volume of 832,394 shares, compared to its average volume of 1,204,557. The firm has a fifty day moving average of $11.56 and a 200-day moving average of $13.14. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The stock has a market cap of $3.20 billion, a price-to-earnings ratio of 45.04 and a beta of 1.88. Sotera Health has a twelve month low of $9.53 and a twelve month high of $17.08.

Analyst Ratings Changes

SHC has been the subject of several analyst reports. Piper Sandler decreased their price objective on Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. Barclays lowered their price target on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $15.20.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.